EXPRS2.ST
Price:
$26.55
Market Cap:
$52.87M
ExpreS2ion Biotech Holding AB (publ), through its subsidiary, ExpreS2 ion Biotechnologies ApS, develops and produces complex proteins for vaccines and diagnostics in Denmark. The company develops capsid virus-like particle COVID-19 vaccine, which is in Phase II clinical trial. It also develops influenza and breast cancer vaccine, which is in Phase II clinical trial, as well as develops malaria vaccine. In addition, the company licenses its ExpreS2 platform to research institutes and pharmaceutical companies. ExpreS2ion Biotech Holding AB (publ) was founded in 2015 is based in Horsholm, Denmark.[Read more]
Industry
Biotechnology
IPO Date
2016-07-29
Stock Exchange
STO
Ticker
EXPRS2.ST
According to ExpreS2ion Biotech Holding AB (publ)’s latest financial reports and current stock price. The company's current PE Ratio is -1.80. This represents a change of -116.52% compared to the average of 10.90 of the last 4 quarters.
The mean historical PE Ratio of ExpreS2ion Biotech Holding AB (publ) over the last ten years is 249.86. The current -1.80 PE Ratio has changed -172.04% with respect to the historical average. Over the past ten years (40 quarters), EXPRS2.ST's PE Ratio was at its highest in in the June 2024 quarter at 233.82. The PE Ratio was at its lowest in in the September 2021 quarter at -1506.45.
Average
249.86
Median
-213.39
Minimum
-1052.55
Maximum
5.50K
Discovering the peaks and valleys of ExpreS2ion Biotech Holding AB (publ) PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 310.53%
Maximum Annual PE Ratio = 5.50K
Minimum Annual Increase = -103.31%
Minimum Annual PE Ratio = -1052.55
Year | PE Ratio | Change |
---|---|---|
2023 | -47.47 | -77.44% |
2022 | -210.39 | -80.01% |
2021 | -1052.55 | 310.53% |
2020 | -256.39 | 74.77% |
2019 | -146.70 | -32.21% |
2018 | -216.40 | -57.69% |
2017 | -511.41 | 36.86% |
2016 | -373.67 | 105.42% |
2015 | -181.91 | -103.31% |
2014 | 5.50K | 146.56% |
The current PE Ratio of ExpreS2ion Biotech Holding AB (publ) (EXPRS2.ST) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
-436.80
5-year avg
-342.70
10-year avg
249.86
ExpreS2ion Biotech Holding AB (publ)’s PE Ratio is less than Bavarian Nordic A/S (22.81), greater than Quantafuel ASA (-2.23), greater than BioPorto A/S (-13.54), less than Zaptec AS (23.39), less than cBrain A/S (55.76),
Company | PE Ratio | Market cap |
---|---|---|
22.81 | $16.25B | |
-2.23 | $1.77B | |
-13.54 | $758.77M | |
23.39 | $928.36M | |
55.76 | $3.94B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ExpreS2ion Biotech Holding AB (publ) using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like ExpreS2ion Biotech Holding AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is ExpreS2ion Biotech Holding AB (publ)'s PE Ratio?
How is the PE Ratio calculated for ExpreS2ion Biotech Holding AB (publ) (EXPRS2.ST)?
What is the highest PE Ratio for ExpreS2ion Biotech Holding AB (publ) (EXPRS2.ST)?
What is the 3-year average PE Ratio for ExpreS2ion Biotech Holding AB (publ) (EXPRS2.ST)?
What is the 5-year average PE Ratio for ExpreS2ion Biotech Holding AB (publ) (EXPRS2.ST)?
How does the current PE Ratio for ExpreS2ion Biotech Holding AB (publ) (EXPRS2.ST) compare to its historical average?